Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory
Corixa Corporation, Hamilton, WA, United States
Search 208 grants from Steven Reed
Search grants from Corixa Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nox4 and Vascular Homeostasis
Development of the Functional Touch Circuit
Synthesis/Distribution of Drugs of Abuse and Opiods
Professional Nurse Traineeship
Composite Material Fabrication and Evaluation Facility
Recently added grants:
Molecular characterization of the multi-modal regulation of inositol 1,4,5-trisphosphate receptors
Cell-type? and developmental stage?specific regulation of gene expression in the retina
Molecular Mechanisms Regulating and Interpreting BMP Signaling
International Federation of Placenta Associations
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI036131-03
Application #
2004119
Study Section
Special Emphasis Panel (ZRG5-MBC-2 (01))
Project Start
1994-09-15
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Corixa Corporation
Department
Type
DUNS #
City
Hamilton
State
WA
Country
United States
Zip Code
Related projects
NIH 1996
R44 AI
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory / Corixa Corporation
NIH 1995
R44 AI
Development of Leishmanial Antigens as Diagnostics
Reed, Steven Gregory / Corixa Corporation
Comments
Be the first to comment on Steven Reed's grant